Search company, investor...

Endocross

endocross.com

Stage

Series A | Alive

Total Raised

$3.45M

Last Raised

$3.45M | 14 yrs ago

About Endocross

Developer of a technology for treating vascular occlusions. The company develops a chronic total occlusions (CTO) crossing devices to enhance safety in peripheral and coronary vessels. Its solution is designed to improve clinical outcome by generating distal forces at the lesion site.

Headquarters Location

Carmel House High-Tech Park (Center)

20692,

Israel

972 4 6669090

Missing: Endocross's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Endocross's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Endocross Patents

Endocross has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/20/2011

2/12/2013

Cardiac procedures, Cardiology, Heart diseases, Angiology, Interventional cardiology

Grant

Application Date

4/20/2011

Grant Date

2/12/2013

Title

Related Topics

Cardiac procedures, Cardiology, Heart diseases, Angiology, Interventional cardiology

Status

Grant

Endocross Frequently Asked Questions (FAQ)

  • What is Endocross's latest funding round?

    Endocross's latest funding round is Series A.

  • How much did Endocross raise?

    Endocross raised a total of $3.45M.

  • Who are the investors of Endocross?

    Investors of Endocross include XT Hi-Tech.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.